Head and neck cancer affects the mouth, throat, nose, sinuses, and the salivary gland. Mary Crowley is committed to expanding options to head and neck cancer patients through the use of investigational targeted, immune and combination therapies.
Liver cancer is rapidly becoming more prevalent in the U.S., with limited approved treatment options. Mary Crowley is currently conducting trials with the HOPE of bringing more effective therapies closer to Food and Drug Administration (FDA) approval.
Neuroendocrine, is a name for cancers that are hormonal in nature and respond to a neurological stimulus. Neuroendocrine tumors are unique, in that they can arise from a multitude of different origins, but are more commonly found in the intestine, pancreas and lungs. Since each one of those organs have different functions, the symptoms associated with the different origins are unique.
Ovarian cancer is hard to detect early. Women with ovarian cancer may have no symptoms or mild symptoms until the disease is in an advanced stage. Watch videoof Mary Crowley ovarian patients, community gynecological oncologists and medical oncologists that speak about the challenges.
As one of the most deadly forms of cancer, Mary Crowley works diligently to find more effective therapies for pancreatic cancer. By providing unique options through clinical trials, we’re providing HOPE that pancreatic cancer will become a more manageable disease.
Squamous cell carcinoma or squamous cell cancer (SCC or SqCC) is a cancer of a kind of epithelial cell, the squamous cell. These cells are the main part of the epidermis of the skin, and this cancer is one of the major forms of skin cancer. However, squamous cells also occur in the lining of the digestive tract, lungs, and other areas of the body, and SCC occurs as a form of cancer in diverse tissues, including the lips, mouth, esophagus, urinary bladder, prostate, lung, vagina, and cervix, among others.